SODIUM VALPROATE( 133MG) & VALPRORIC ACID (58MG) MGCONTROLLED RELEASE TABLET

SODIUM VALPROATE( 133MG) & VALPRORIC ACID (58MG) MGCONTROLLED RELEASE TABLET Specification

Form
Controlled Release Tablet

Dosage Form
Oral

Color
White to off-white

Prescription/Non prescription
Prescription

Storage
Store below 30°C, protected from moisture and light

Composition
Sodium Valproate 133mg & Valproic Acid 58mg

Packing Type
Blister Pack

Manufacturing Process
Controlled Release

Shape
Round

Strength
191mg (133mg Sodium Valproate + 58mg Valproic Acid)

Usage
Antiepileptic / Anticonvulsant

Shelf Life
24 months

About SODIUM VALPROATE( 133MG) & VALPRORIC ACID (58MG) MGCONTROLLED RELEASE TABLET

Experience a kingly antiepileptic solution with our premier SODIUM VALPROATE (133MG) & VALPROIC ACID (58MG) MG CONTROLLED RELEASE TABLET, now at a reduced price! This trending deal is crafted for reliable seizure control, blending renowned efficacy with modern controlled-release technology. Each round, white to off-white tablet (191mg total strength) delivers precision dosing and extended action, ensuring optimal patient outcomes. Presented in secure blister packing, each batch is freshly manufactured with a shelf life of 24 months. Ideal for exporters, suppliers, and medical traders, this prescription-only medication keeps safety foremost-store below 30C, shielded from moisture and light.

Specialty Use and Commercial Advantages

SODIUM VALPROATE (133MG) & VALPROIC ACID (58MG) MG CONTROLLED RELEASE TABLET is specifically used as an antiepileptic and anticonvulsant, making it crucial for patients managing seizure disorders. Its controlled release formulation ensures consistent medication levels, enhancing patient compliance and therapeutic results. As a commercially renowned product, it offers procurement advantages for traders and healthcare institutions, ensuring steady supply and regulatory compliance for widespread medical usage both domestically and internationally.

Sample Policy & Export Market Focus

Our export market coverage is extensive, serving premier regions with efficient delivery and customer-focused sample policies. While sample charges are minimal, potential buyers may incur basic expenditure for logistics. We prioritize the main domestic market in India while actively supplying international buyers as leading exporters and suppliers. This blend of flexible sampling options and expansive market presence positions us as a trusted trader and manufacturer in the global pharmaceutical industry.

FAQ's of SODIUM VALPROATE( 133MG) & VALPRORIC ACID (58MG) MGCONTROLLED RELEASE TABLET:

Q: How should SODIUM VALPROATE & VALPROIC ACID MG CONTROLLED RELEASE TABLET be used?

A: This medication should be taken orally as prescribed by a healthcare professional, typically for the treatment of epilepsy or seizure disorders. Dosing is individualized based on patient response and medical supervision.

Q: What makes this antiepileptic tablet a competitive option in the market?

A: Its controlled release formulation, renowned efficacy, and quality manufacturing make it a premier choice. Additionally, its availability at a reduced price and reliable supply adds to its commercial appeal.

Q: When and where is this product manufactured and supplied?

A: Manufactured in India with stringent quality controls, it is supplied domestically and exported to key international markets by leading traders and exporters.

Q: What is the process for obtaining product samples?

A: Interested buyers can request samples, subject to a nominal charge and delivery expenditure. The sample policy is designed to facilitate easy evaluation for bulk purchasing or distribution.

Q: What are the main benefits of the controlled release technology applied in this tablet?

A: Controlled release technology ensures steady medication levels in the body, reducing dosing frequency and enhancing patient compliance and overall therapeutic efficacy.

Tell us about your requirement